Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model
A Breakthrough in COVID-19 Therapeutics: Synergistic Targeting of SARS-CoV-2 PLpro and Host RIPK1 Yields Promising Results in Preclinical Models The...




















